S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:AZTA

Azenta News Headlines

$69.62
-0.64 (-0.91%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$67.19
$72.06
50-Day Range
$64.69
$88.55
52-Week Range
$61.35
$124.79
Volume
639,698 shs
Average Volume
651,401 shs
Market Capitalization
$5.22 billion
P/E Ratio
2.36
Dividend Yield
0.43%
Beta
1.66
Get Azenta News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZTA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Azenta Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZTA
News Sentiment

-0.44

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZTA Articles
This Week

16

2

AZTA Articles
Average Week



Azenta (NASDAQ:AZTA) News Headlines Today

SourceHeadline
marketbeat.com logo$0.10 EPS Expected for Azenta, Inc. (NASDAQ:AZTA) This Quarter
marketbeat.com - May 20 at 4:18 PM
marketbeat.com logoB. Riley Analysts Decrease Earnings Estimates for Azenta, Inc. (NASDAQ:AZTA)
marketbeat.com - May 20 at 7:52 AM
marketbeat.com logoAzenta, Inc. Forecasted to Earn FY2024 Earnings of $1.39 Per Share (NASDAQ:AZTA)
marketbeat.com - May 19 at 7:25 AM
marketbeat.com logoB. Riley Cuts Azenta (NASDAQ:AZTA) Price Target to $94.00
marketbeat.com - May 17 at 8:30 AM
marketbeat.com logoAzenta (NASDAQ:AZTA) Issues Q3 2022 Earnings Guidance
marketbeat.com - May 16 at 7:38 AM
MarketBeat logoFY2024 EPS Estimates for Azenta, Inc. Lowered by Analyst (NASDAQ:AZTA)
americanbankingnews.com - May 21 at 3:24 AM
MarketBeat logoQ3 2022 EPS Estimates for Azenta, Inc. Cut by B. Riley (NASDAQ:AZTA)
americanbankingnews.com - May 21 at 2:00 AM
MarketBeat logoAzenta (NASDAQ:AZTA) PT Lowered to $94.00
americanbankingnews.com - May 19 at 4:24 AM
markets.businessinsider.com logoExpert Ratings for Azenta
markets.businessinsider.com - May 17 at 5:55 PM
MarketBeat logoKeyCorp Weighs in on Azenta, Inc.'s Q3 2022 Earnings (NASDAQ:AZTA)
americanbankingnews.com - May 13 at 2:35 AM
MarketBeat logoQ4 2022 EPS Estimates for Azenta, Inc. (NASDAQ:AZTA) Lifted by Analyst
americanbankingnews.com - May 12 at 2:14 AM
MarketBeat logoAzenta (NASDAQ:AZTA) Price Target Cut to $94.00 by Analysts at Needham & Company LLC
americanbankingnews.com - May 11 at 4:54 AM
MarketBeat logoAzenta (NASDAQ:AZTA) Shares Gap Down After Analyst Downgrade
americanbankingnews.com - May 11 at 1:34 AM
nasdaq.com logoNoteworthy Monday Option Activity: AZTA, CELH, MAXR
nasdaq.com - May 9 at 7:18 PM
investing.com logoAzenta, Inc. Tops Q2 EPS by 1c, Offers Guidance
investing.com - May 9 at 7:18 PM
seekingalpha.com logoAzenta, Inc. (AZTA) CEO Steve Schwartz on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 7:18 PM
nasdaq.com logoAzenta Enters Oversold Territory (AZTA)
nasdaq.com - May 9 at 7:18 PM
MarketBeat logoAzenta (NASDAQ:AZTA) Reaches New 12-Month Low at $69.68
americanbankingnews.com - May 8 at 4:24 AM
MarketBeat logoAzenta (AZTA) Set to Announce Earnings on Monday
americanbankingnews.com - May 8 at 2:00 AM
MarketBeat logoAzenta (AZTA) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - May 7 at 1:20 AM
seekingalpha.com logoAzenta Q2 2022 Earnings Preview
seekingalpha.com - May 6 at 6:44 PM
finance.yahoo.com logoInvestors in Azenta (NASDAQ:AZTA) have made a strong return of 178% over the past five years
finance.yahoo.com - May 6 at 6:44 PM
MarketBeat logoAzenta (NASDAQ:AZTA) Upgraded by Zacks Investment Research to "Hold"
americanbankingnews.com - May 4 at 4:28 AM
MarketBeat logoAzenta (NASDAQ:AZTA) Upgraded at Zacks Investment Research
americanbankingnews.com - April 29 at 4:34 AM
MarketBeat logoHead-To-Head Contrast: Azenta (NASDAQ:AZTA) and Katy Industries (OTCMKTS:KATYQ)
americanbankingnews.com - April 28 at 1:24 AM
finance.yahoo.com logoAnalysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 26 at 5:46 PM
finance.yahoo.com logoAzenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate
finance.yahoo.com - March 31 at 3:20 PM
markets.businessinsider.com logoAzenta to Participate in the 21st Annual Needham Virtual Healthcare Conference
markets.businessinsider.com - March 30 at 6:27 PM
finance.yahoo.com logoAzenta to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
finance.yahoo.com - March 11 at 11:20 AM
finance.yahoo.com logoAzenta to Participate in the Cowen 42nd Annual Health Care Conference
finance.yahoo.com - February 25 at 8:20 AM
finance.yahoo.com logoHere's Why Azenta (NASDAQ:AZTA) Can Manage Its Debt Responsibly
finance.yahoo.com - February 15 at 11:49 AM
finance.yahoo.com logoAzenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021
finance.yahoo.com - February 8 at 4:16 PM
finance.yahoo.com logoAzenta Life Sciences Completes Sale of Semiconductor Solutions Group Business to Thomas H. Lee Partners
finance.yahoo.com - February 1 at 5:37 PM
finance.yahoo.com logoAzenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and Webcast
finance.yahoo.com - January 24 at 10:28 AM
finance.yahoo.com logoTop Robotics Stocks for Q1 2022
finance.yahoo.com - January 12 at 9:03 PM
finance.yahoo.com logoAzenta Life Sciences Names Matthew McManus Chief Operating Officer
finance.yahoo.com - January 6 at 5:55 PM
finance.yahoo.com logoAzenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference
finance.yahoo.com - December 21 at 9:03 PM
finance.yahoo.com logoAzenta Life Sciences to Participate in the 24th Annual Needham Virtual Growth Conference
finance.yahoo.com - December 20 at 6:11 PM
Get Azenta News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZTA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.